Q2 2016 Holdings
Filed 2016-08-12 | 49 holdings | $25.0M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2016-08-12) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axogen Inc(AXGN)A | COM | 05463X106 | $14.6M | 2,120,000 | 58.4% |
| Codexis Inc(CDXS)A | COM | 192005106 | $4.7M | 1,178,500 | 19.0% |
| Agios Pharmaceuticals(AGIO)A | COM | 00847X104 | $3.6M | 85,000 | 14.3% |
| Cytomx Therapeutics Inc(CTMX)A | COM | 23284F105 | $1.6M | 160,000 | 6.5% |
| Adaptimmune Therapeutics PLC(ADAPY)A | SPONDS ADR | 00653A107 | $326.0K | 40,000 | 1.3% |
| Medgenics IncA | COM NEW | 58436Q203 | $10.8K | 1,950,000 | 0.0% |
| Ariad Pharmaceuticals IncA | COM | 04033A100 | $9.2K | 1,250,000 | 0.0% |
| Fibrogen Inc(FGENEUR)A | COM | 31572Q808 | $5.4K | 330,000 | 0.0% |
| Protalix Biotherapeutics IncA | COM | 74365AAB7 | $5.2K | 8,200,000 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 683745103 | $5.2K | 8,200,000 | 3.5% |
| Blueprint Medicines Corp(2L9)A | COM | 09627Y109 | $5.1K | 250,000 | 0.0% |
| Inotek Pharmaceuticals Corp | COM | 45780VAA0 | $4.8K | 645,000 | 0.0% |
| Imprimis Pharmaceuticals IncA | COM NEW | 45323A201 | $4.8K | 1,267,500 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR)A | COM | 00548A106 | $4.5K | 300,000 | 0.0% |
| Adamas Pharmaceuticals Inc | COM | 004449104 | $4.5K | 300,000 | 3.0% |
| Foamix Pharmaceuticals LTDA | SHS | M46135105 | $4.4K | 695,000 | 0.0% |
| Cara Therapeutics Inc(CARAEUR)A | COM | 140755109 | $4.0K | 835,000 | 0.0% |
| Amarin Corp PLCA | SPONS ADR NEW | 023111206 | $3.8K | 1,760,000 | 0.0% |
| Horizon Pharma PLCA | COM | G4617B105 | $3.3K | 200,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $3.2K | 65,000 | 0.0% |
| Macrogenics Inc | COM | 58501N101 | $3.0K | 112,000 | 2.0% |
| Macrogenics Inc(MGNX)A | COM | 556099109 | $3.0K | 112,000 | 0.0% |
| Immunomedics Inc(IMMU)A | COM | 452907108 | $3.0K | 1,300,000 | 0.0% |
| Immunomedics Inc(GERN) | COM | 374163103 | $3.0K | 1,300,000 | 2.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $3.0K | 650,000 | 0.0% |
| Amag Pharmaceuticals Inc(AMAG)A | COM | 00163U106 | $2.9K | 120,000 | 0.0% |
| Chimerix Inc(CMRXEUR)A | COM | 16934W106 | $2.7K | 675,000 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN)A | COM | 868459108 | $2.5K | 125,000 | 0.0% |
| Supernus Pharmaceuticals Inc(SG7) | COM | 78667J108 | $2.5K | 125,000 | 1.7% |
| Global Blood Therapeutics inA | COM | 37890U108 | $2.5K | 152,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.4K | 410,000 | 0.0% |
| Edge Therapeutics Inc | COM | 249908104 | $2.3K | 225,600 | 1.5% |
| Edge Therapeutics IncA | COM | 279870109 | $2.3K | 225,600 | 0.0% |
| Lion Biotechnologies IncA | COM | 53619R102 | $2.1K | 260,000 | 0.0% |
| Cynapsus Therapeutics IncA | COM PAR NO PAR | 23257Y859 | $2.1K | 125,000 | 0.0% |
| Paratek Pharmaceuticals IncA | COM | 699374302 | $2.0K | 146,700 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 67778H200 | $2.0K | 146,700 | 1.4% |
| Nabriva Therapeutics AGA | SPONSORED ADR | 62957M104 | $2.0K | 270,000 | 0.0% |
| Nabriva Therapeutics AG(NKTREUR) | COM | 640268108 | $2.0K | 270,000 | 1.4% |
| Aquinox Pharmaceuticals IncA | COM | 03842B101 | $2.0K | 295,000 | 0.0% |
| Eagle Pharmaceuticals Inc | COM | 838828509 | $1.9K | 50,000 | 1.3% |
| Eagle Pharmaceuticals Inc(EGRX)A | COM | 269796108 | $1.9K | 50,000 | 0.0% |
| Zogenix Inc | COM | 98419J107 | $1.9K | 240,000 | 1.3% |
| Zogenix IncA | COM NEW | 98978L105 | $1.9K | 240,000 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $1.8K | 195,000 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR)A | COM | 81750R102 | $1.7K | 57,500 | 0.0% |
| Seres Therapeutics Inc | COM | 761299106 | $1.7K | 57,500 | 1.1% |
| Tonix Pharmaceuticals Hldg CA | COM NEW | 890260201 | $1.6K | 800,000 | 0.0% |
| Affimed NVA | COM | N01045108 | $1.5K | 595,000 | 0.0% |
| Innocoll Holdings PLCA | SHS | G4783X105 | $1.5K | 265,000 | 0.0% |